Navigation Links
BD Adds Surveillance Capability to Infectious Disease Portfolio
Date:8/6/2009

SPARKS, Md., Aug. 6 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.

Through the acquisition of ICPA, Inc., a privately held corporation based in Austin, TX, BD adds a proprietary software system with the ability to track and monitor emerging infection issues.

"This strategic expansion of BD's portfolio enables us to provide a set of integrated information solutions to clinicians striving to reduce the incidence and transmission of infections in their facilities," said Philippe Jacon, President of BD Diagnostics - Diagnostic Systems.

BD provides products throughout the continuum of infection prevention and control. These include safety-engineered collection devices, rapid assays to detect the presence of infectious organisms, and devices to reduce the risk of infections and enable the timely delivery of appropriate, directed therapies.

ICPA's AICE(R) software uses an integrated data warehouse to generate alerts that signal emerging infection control issues. By providing automated, evidence-based surveillance capabilities, the system makes it easier for infection preventionists to focus on implementing processes and interventions that can help prevent the incidence and transmission of healthcare-associated infections (HAIs). AICE software tracks emerging drug-resistant organisms and the incidence of HAIs. It also supports compliance with mandated infection reporting requirements by the U.S. Centers for Disease Control and Prevention, as well as participation in the National Healthcare Safety Network.

The AICE software is designed to continuously interpret and aggregate data used by infection preventionists via multiple electronic interfaces to hospital database systems. Access to real-time diagnostic and demographic data allows the system to alert infection preventionists to critical events that require immediate attention.

"For the last 20 years, ICPA's mission has been to deliver healthcare software for the purpose of improving patient care and employee health. Our mission fits perfectly with BD's purpose of 'helping all people live healthy lives,'" said ICPA CEO Deborah Martin, RN, MN, FSHEA, who will join BD as WW Director, Infection Prevention, BD Diagnostics - Diagnostic Systems.

ICPA, Inc. is a leading provider of software solutions for the healthcare industry, specializing in infectious disease surveillance and employee health. Founded in 1984, it supports an installation base of over 750 customers throughout the United States, Canada and Europe. For more information, please visit www.bd.com/ds/informatics.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com/" target="_new">www.bd.com.


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GVI Security Solutions Samsung Video Surveillance Solution Selected by North East Pharmacy Chain
2. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
3. Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
4. Select Telecom Adds Surveillance System Installation and Maintenance Services, Receives New York State License
5. Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem
6. APIC Supports Automated Surveillance Technologies in Prevention of Healthcare-Associated Infections
7. Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe
8. Pittsburgh Life Sciences Company Using Community Health Surveillance Platform to Track H1N1 Flu (Swine Flu)
9. GVI Security Solutions Provides Video Surveillance Solution for One of the Largest Health Care Organizations in Colombia
10. As SEIU Prepares Hostile Takeover of United Healthcare Workers, Surveillance of Local Union Office Ends in Assault by Off-Duty Police Officer
11. BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... the American Academy of Dermatology Annual Meeting at the Walter E. Washington Convention ... raise awareness for both the condition of hyperhidrosis (excessive sweating) and its treatment ...
(Date:2/11/2016)... ... 11, 2016 , ... Husted Kicking has completed its Third Annual ... 6th & 7th, 2016 according to kicking coach Michael Husted. , “This event serves ... NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party organization to ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... The book, ... for IT services, what questions to ask your IT consultant before signing a contract ... to your computer network. , “With companies relying heavily on e-mail and technology, it’s ...
(Date:2/11/2016)... ... , ... As part of their 2015 end of year funding strategy, ... has gifted $10,000 to University of Chicago to support ovarian cancer research being conducted ... are honored to support a promising young investigator from Dr. Lengyel’s lab at the ...
(Date:2/10/2016)... City, California (PRWEB) , ... February 10, 2016 ... ... Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will be ... theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will highlight ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016  Ampio Pharmaceuticals, Inc. (NYSE MKT: ... entered into a Controlled Equity Offering SM Sales ... Michael Macaluso , Chairman and CEO, stated "During ... are not currently raising money and that we have ... 2017 and still complete all of our current objectives ...
(Date:2/11/2016)... Germany , February 11, 2016 ... up 6.8% to EUR 1,377.2m  Adjusted EBITDA climbs to ... 18.0% to EUR 3.41  Proposed dividend of EUR 0.85 ... sale of glass tubing business and refinancing successfully completed  ... to 5% on organic basis  Adjusted EBITDA expected ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
Breaking Medicine Technology: